These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12871373)

  • 21. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
    Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
    Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of conversion of plasminogen activator inhibitor 1 from a suicide inhibitor to a substrate by monoclonal antibodies.
    Komissarov AA; Declerck PJ; Shore JD
    J Biol Chem; 2002 Nov; 277(46):43858-65. PubMed ID: 12223472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Function-stabilizing mechanism of plasminogen activator inhibitor type 1 induced upon binding to alpha1-acid glycoprotein.
    Smolarczyk K; Gils A; Boncela J; Declerck PJ; Cierniewski CS
    Biochemistry; 2005 Sep; 44(37):12384-90. PubMed ID: 16156651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition.
    Lawrence DA; Olson ST; Palaniappan S; Ginsburg D
    J Biol Chem; 1994 Nov; 269(44):27657-62. PubMed ID: 7961684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of helix F in plasminogen activator inhibitor-1.
    Vleugels N; Gils A; Bijnens AP; Knockaert I; Declerck PJ
    Biochim Biophys Acta; 2000 Jan; 1476(1):20-6. PubMed ID: 10606763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of functional synergism between monoclonal antibodies. Application to the enhancement of plasminogen activator inhibitor-1 neutralizing effects.
    Ngo TH; Debrock S; Declerck PJ
    FEBS Lett; 1997 Oct; 416(3):373-6. PubMed ID: 9373188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
    Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA
    Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator.
    Björquist P; Ehnebom J; Inghardt T; Deinum J
    Biochim Biophys Acta; 1997 Aug; 1341(1):87-98. PubMed ID: 9300812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering of conformations of plasminogen activator inhibitor-1. A crucial role of beta-strand 5A residues in the transition of active form to latent and substrate forms.
    Kirkegaard T; Jensen S; Schousboe SL; Petersen HH; Egelund R; Andreasen PA; Rodenburg KW
    Eur J Biochem; 1999 Jul; 263(2):577-86. PubMed ID: 10406969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.
    Gils A; Knockaert I; Declerck PJ
    Biochemistry; 1996 Jun; 35(23):7474-81. PubMed ID: 8652525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated conversion of human plasminogen activator inhibitor-1 to its latent form by antibody binding.
    Verhamme I; Kvassman JO; Day D; Debrock S; Vleugels N; Declerck PJ; Shore JD
    J Biol Chem; 1999 Jun; 274(25):17511-7. PubMed ID: 10364183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning of a single-chain variable fragment (scFv) switching active plasminogen activator inhibitor-1 to substrate.
    Debrock S; Sironi L; Declerck PJ
    Gene; 1997 Apr; 189(1):83-8. PubMed ID: 9161416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.
    Xue Y; Björquist P; Inghardt T; Linschoten M; Musil D; Sjölin L; Deinum J
    Structure; 1998 May; 6(5):627-36. PubMed ID: 9634700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redirection of the reaction between activated protein C and a serpin to the substrate pathway.
    Komissarov AA; Andreasen PA; Declerck PJ; Kamikubo Y; Zhou A; Gruber A
    Thromb Res; 2008; 122(3):397-404. PubMed ID: 18045665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of epitopes for monoclonal antibodies to urokinase-type plasminogen activator: relationship between epitope localization and effects of antibodies on molecular interactions of the enzyme.
    Petersen HH; Hansen M; Schousboe SL; Andreasen PA
    Eur J Biochem; 2001 Aug; 268(16):4430-9. PubMed ID: 11502203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of common neoantigenic epitopes generated in plasminogen activator inhibitor-1 after cleavage of the reactive center loop or after complex formation with various serine proteinases.
    Debrock S; Declerck PJ
    FEBS Lett; 1995 Dec; 376(3):243-6. PubMed ID: 7498551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of plasminogen activator inhibitor-1.
    Wind T; Jensen JK; Dupont DM; Kulig P; Andreasen PA
    Eur J Biochem; 2003 Apr; 270(8):1680-8. PubMed ID: 12694181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological detection of conformational neoepitopes associated with the serpin activity of plasminogen activator inhibitor type-2.
    Saunders DN; Buttigieg KM; Gould A; McPhun V; Baker MS
    J Biol Chem; 1998 May; 273(18):10965-71. PubMed ID: 9556575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the vitronectin binding site on plasminogen activator inhibitor 1 (PAI-1).
    van Meijer M; Gebbink RK; Preissner KT; Pannekoek H
    FEBS Lett; 1994 Oct; 352(3):342-6. PubMed ID: 7523190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activator.
    van Meijer M; Roelofs Y; Neels J; Horrevoets AJ; van Zonneveld AJ; Pannekoek H
    J Biol Chem; 1996 Mar; 271(13):7423-8. PubMed ID: 8631768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.